CD24 was specifically overexpressed in the tumor compartment, orchestrates a novel innate immune checkpoint through interaction with the inhibitory receptor sialic acid-binding Ig-like lectin 10 (Siglec-10) on tumor-associated macrophages in primary ovarian and breast cancer samples [32]. Here, CD24 is linked to breast cancer.